| Proposal for a new tool to evaluate drug interaction cases JR Horn, PD Hansten, LN Chan Annals of Pharmacotherapy 41 (4), 674-680, 2007 | 642 | 2007 |
| The proton-pump inhibitors: similarities and differences J Horn Clinical therapeutics 22 (3), 266-280, 2000 | 374 | 2000 |
| Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know M Robinson, J Horn Drugs 63, 2739-2754, 2003 | 311 | 2003 |
| Drug interactions: analysis and management PD Hansten, JR Horn Wolters Kluwer Health, 2006 | 208 | 2006 |
| Performance of community pharmacy drug interaction software TK Hazlet, TA Lee, PD Hansten, JR Horn Journal of the American Pharmaceutical Association (1996) 41 (2), 200-204, 2001 | 186 | 2001 |
| Toward a complete dataset of drug–drug interaction information from publicly available sources S Ayvaz, J Horn, O Hassanzadeh, Q Zhu, J Stan, NP Tatonetti, S Vilar, ... Journal of biomedical informatics 55, 206-217, 2015 | 166 | 2015 |
| Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and γ-hydroxybutyrate RD Harrington, JA Woodward, TM Hooton, JR Horn Archives of Internal Medicine 159 (18), 2221-2224, 1999 | 164 | 1999 |
| Consensus recommendations for systematic evaluation of drug–drug interaction evidence for clinical decision support RT Scheife, LE Hines, RD Boyce, SP Chung, JD Momper, CD Sommer, ... Drug safety 38, 197-206, 2015 | 140 | 2015 |
| ORCA: OpeRational ClassificAtion of drug interactions PD Hansten, JR Horn, TK Hazlet Journal of the American Pharmaceutical Association (1996) 41 (2), 161-165, 2001 | 134 | 2001 |
| The top 100 drug interactions: a guide to patient management PD Hansten, JR Horn H & H Publications, LLP, 2004 | 124 | 2004 |
| The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers AJ Wright, T Gomes, MM Mamdani, JR Horn, DN Juurlink Cmaj 183 (3), 303-307, 2011 | 123 | 2011 |
| Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy LA Bauer, M Stenwall, JR Horn, R Davis, K Opheim, L Greene Clinical Pharmacology & Therapeutics 40 (2), 239-242, 1986 | 113 | 1986 |
| relationship between the metabolism and efficacy of proton pump inhibitors–focus on rabeprazole J Horn Alimentary pharmacology & therapeutics 20, 11-19, 2004 | 112 | 2004 |
| Accuracy of duplex scanning for measurement of arterial volume flow BK Zierler, TR Kirkman, LW Kraiss, WG Reiss, JR Horn, LA Bauer, ... Journal of vascular surgery 16 (4), 520-526, 1992 | 95 | 1992 |
| Drug interactions analysis and management PD Hansten, JR Horn (No Title), 1997 | 87 | 1997 |
| Coping with common gastrointestinal symptoms in the community: a global perspective on heartburn, constipation, bloating, and abdominal pain/discomfort May 2013 R Hunt, E Quigley, Z Abbas, A Eliakim, A Emmanuel, KL Goh, F Guarner, ... Journal of clinical gastroenterology 48 (7), 567-578, 2014 | 85 | 2014 |
| Warfarin-induced skin necrosis: report of four cases JR Horn, LH Danziger, RJ Davis American Journal of Hospital Pharmacy 38 (11), 1763-1768, 1981 | 76 | 1981 |
| Therapeutic drug monitoring reduces toxic drug reactions: a meta-analysis LD Ried, JR Horn, DA McKenna Therapeutic drug monitoring 12 (1), 72-78, 1990 | 69 | 1990 |
| Hansten and Horn's drug interactions analysis and managenent PD Hansten, JR Horn (No Title), 1997 | 64 | 1997 |
| Cyclosporine–drug interactions and the influence of patient age J Lill, LA Bauer, JR Horn, PD Hansten American Journal of Health-System Pharmacy 57 (17), 1579-1584, 2000 | 63 | 2000 |
